Irish Medical News

header4

Product News

Performance intelligence future of healthcare

E-mail

TRAG Performance Intelligence Group Ireland and UK (TRAGPI) is an advisory company focused on providing integrated cost and quality management solutions to healthcare institutions. TRAGPI’s mission is to assist hospitals worldwide to deliver the best possible quality of healthcare per euro spent.

 

 

New data on Zytiga presented at ASCO

E-mail

 

Data related to Zytiga (abiraterone acetate) clinical studies have been selected for presentation at the 48th Annual Meeting of the American Society of Clinical Oncology (ASCO) later this month, Janssen has announced.

 

MSD Launches Elonva in Ireland

E-mail

 

MSD has announced the availability of Elonva in Ireland (corifollitropin alfa injection), a new treatment for fertility. Elonva is approved for controlled ovarian stimulation (COS) in combination with a gonadotropin-releasing hormone (GnRH) antagonist for the development of multiple follicles in women participating in an assisted reproductive technology (ART) programme.

 

Campaign to highlight awareness of sight-threatening condition in people with diabetes

E-mail

According to research, over three quarters (75 per cent) of people with diabetes in Ireland have not heard of the condition diabetic macular oedema (DMe).

 

Boots Ireland lowers cost of prescription medicines

E-mail

 

Boots Ireland has announced new lower prescription medicine prices. The changes will reduce the price of the majority of prescription medicines.

 
  • «
  •  Start 
  •  Prev 
  •  1 
  •  2 
  •  3 
  •  4 
  •  5 
  •  6 
  •  7 
  •  8 
  •  9 
  •  10 
  •  Next 
  •  End 
  • »
Page 1 of 21

Weather

IMN Poll

Do you agree with the Government’s decision to locate the new children’s hospital at St James’s Hospital?
 

More News

NewsNews
IMO to discuss consultant survey results
Paul MulhollandTuesday, 22 March 2011

The results of an IMO benchmark study into the professional lives of consultants is due to be discussed at the Organisation’s consultant meeting at the end of the month. IMO President Professor Sean Tierney told IMN that the results of the survey, which was conducted by the market research company, Behaviour and Attitudes, are in the process of being finalised at present. “We have had meetings with the people who conducted the survey, and are now getting back the data,” Prof Tierney said.

Read more…

You are here: Home Clinical Product News